Literature DB >> 14729768

Methotrexate eluting stents: to modify or cure?

A C Morton, J Gunn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14729768      PMCID： PMC1768049          DOI： 10.1136/hrt.2003.019638

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  13 in total

Review 1.  Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.

Authors:  M Cutolo; A Sulli; C Pizzorni; B Seriolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

Review 2.  Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group.

Authors:  Robert S Schwartz; Elazer R Edelman; Andrew Carter; Nicolas Chronos; Campbell Rogers; Keith A Robinson; Ron Waksman; Judah Weinberger; Robert L Wilensky; Donald N Jensen; Bram D Zuckerman; Renu Virmani
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

3.  Images in cardiovascular medicine. Late-late occlusion after intracoronary brachytherapy.

Authors:  Georgios Sianos; Nico Mollet; Sjoerd Hofma; Pim J de Feyter; Patrick W Serruys
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

4.  Multiple percutaneous transluminal angioplasties and low dose pulse methotrexate for Takayasu's arteritis.

Authors:  G C Liang; R Nemickas; M Madayag
Journal:  J Rheumatol       Date:  1989-10       Impact factor: 4.666

5.  Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility.

Authors:  N Malik; J Gunn; L Shepherd; D C Crossman; D C Cumberland; C M Holt
Journal:  J Invasive Cardiol       Date:  2001-03       Impact factor: 2.022

6.  Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate.

Authors:  S Hirata; T Matsubara; R Saura; H Tateishi; K Hirohata
Journal:  Arthritis Rheum       Date:  1989-09

7.  Coronary artery stretch versus deep injury in the development of in-stent neointima.

Authors:  J Gunn; N Arnold; K H Chan; L Shepherd; D C Cumberland; D C Crossman
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

8.  Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.

Authors:  Y Huang; K Salu; X Liu; S Li; L Wang; E Verbeken; J Bosmans; I De Scheerder
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

9.  Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model.

Authors:  R S Schwartz; K C Huber; J G Murphy; W D Edwards; A R Camrud; R E Vlietstra; D R Holmes
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

10.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Authors:  Jeffrey W Moses; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; David R Holmes; Charles O'Shaughnessy; Ronald P Caputo; Dean J Kereiakes; David O Williams; Paul S Teirstein; Judith L Jaeger; Richard E Kuntz
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.